SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-20-000664
Filing Date
2020-02-03
Accepted
2020-02-03 16:30:12
Documents
2
Period of Report
2020-02-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_020320.htm 8-K 19439
2 PRESS RELEASE exh_991.htm EX-99.1 6147
  Complete submission text file 0001171843-20-000664.txt   26917
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 20569047
SIC: 3841 Surgical & Medical Instruments & Apparatus